Ellington Credit Company (EARN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for September 26, 2024, to vote on key proposals supporting a strategic transformation to a CLO-focused investment strategy and conversion to a Delaware statutory trust and registered closed-end fund structure.
Board unanimously recommends approval of all proposals, which are required to complete the transformation and conversion.
Strategic transformation includes revocation of REIT status, temporary operation as a C-Corp, and planned conversion to a regulated investment company (RIC) under the 1940 Act.
Name changed to Ellington Credit Company, with continued NYSE listing under ticker EARN.
Voting matters and shareholder proposals
Six trustees nominated for election; all current trustees are standing for re-election.
Proposals include: change of legal form to Delaware statutory trust, approval of amended Declaration of Trust, approval of new investment advisory agreement, advisory vote on executive compensation, and ratification of PwC as auditor.
Board recommends voting FOR all proposals; approval of Proposals 2-4 is required for the strategic transformation.
If contingent proposals fail, the company will not proceed with the conversion.
Board of directors and corporate governance
Board consists of six trustees, four of whom are independent under NYSE standards.
Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, all comprised solely of independent trustees.
Board and committees met regularly in 2023, with high attendance and executive sessions held quarterly.
Board leadership structure separates CEO and Chairman roles.
Latest events from Ellington Credit Company
- Disciplined risk management and dynamic CLO investing drive strong returns and portfolio resilience.EARN
Investor presentation16 Mar 2026 - GAAP net loss of $21.1M and NAV per share of $5.19 amid CLO equity market headwinds.EARN
Q4 20255 Mar 2026 - CLO portfolio nearly doubled to $85.1M as leverage fell and dividend coverage remained strong.EARN
Q2 20241 Feb 2026 - Q3 2024 net income hit $5.4M as CLO allocation rose to 58% and leverage fell.EARN
Q3 202414 Jan 2026 - Q4 net loss offset by robust CLO growth and RIC conversion, driving future value creation.EARN
Q4 202425 Dec 2025 - Shareholders to vote on major transformation to CLO-focused strategy, governance, and structure.EARN
Proxy Filing1 Dec 2025 - Shareholders are encouraged to vote FOR all six proposals at the 2024 virtual annual meeting.EARN
Proxy Filing1 Dec 2025 - Shareholders will vote on key proposals to enable a full transition to a CLO-focused closed-end fund.EARN
Proxy Filing1 Dec 2025 - Postponed annual meeting centers on shareholder vote for conversion to a CLO-focused fund.EARN
Proxy Filing1 Dec 2025